From Illumina.com: Using whole-genome sequencing to study early-onset Parkinson’s disease

Written By Kim Markworth

Working with Illumina, with generous funding from ASAP, NysnoBio is honored to be featured—and to share some of our discovery work that helps drive our clinical innovations!

Read the article here.

Contact NysnoBio to get involved or learn more:
info@nysnobio.com

Kim Markworth

CEO / Creative Director

Markworth Creative Advertising & Design

Since 1998

https://markworthcreative.com
Previous

“Nature Reviews Neurology” Review Article: Functional brain networks in the evaluation of patients with neurodegenerative disorders
Next

NysnoBio Partner, Rune Labs, Announces FDA Clearance for StrivePD App